Acute pharmacologic poisoning (I). Psychotropic and antiarrhythmic drugs;Intoxicaciones medicamentosas (I). Psicofármacos y antiarrítmicos

Anales del Sistema Sanitario de Navarra

Volumn 26, Issue SUPPL. 1, 2003, Pages 49-63

  Oses I ^a   Burillo Putze, G ^b   Munne P ^c   Nogue S ^c   Pinilloss, M A ^a  

^a Universidad Pública de Navarra   (Spain)

^b HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

bloqueants; Benzodiazepines; Digoxine; Poisoning; Tricylcic antidepressants

Indexed keywords

ACTIVATED CARBON; ALPRAZOLAM; ANTIARRHYTHMIC AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BROMAZEPAM; CALCIUM ANTAGONIST; CARDIOVASCULAR AGENT; CLONAZEPAM; CLORAZEPATE DIPOTASSIUM; DIAZEPAM; DIGOXIN; DORKEN; FLUMAZENIL; FLUNITRAZEPAM; GLUCAGON; IDALPREM; ISOPRENALINE; KETAZOLAM; LIDOCAINE; LITHIUM; LOPRAZOLAM; LORAZEPAM; LORMETAZEPAM; MAGNESIUM; MARCEN; MIDAZOLAM; MIDAZOLAM MALEATE; ORFIDAL; PHENYTOIN; PROPRANOLOL; PSYCHOTROPIC AGENT; SEDOTIME; SOMNOVIT; TRANKIMACIN; TRIAZOLAM; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

AIRWAY; ANAMNESIS; DIAGNOSTIC TEST; DRUG INTOXICATION; ELECTROCARDIOGRAM; HEMODIALYSIS; HUMAN; NEUROTOXICITY; OXYGENATION; PATIENT MONITORING; REVIEW;

ACUTE DISEASE; ANTI-ARRHYTHMIA AGENTS; HUMANS; POISONING; PSYCHOTROPIC DRUGS;

EID: 0038270626     PISSN: 11376627     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. BURILLO-PUTZE G, MUNNE P, DUEÑAS A, PINILLOS MA, NAVIERO JM, COBO J et al. National multicenter study of acute intoxication in Emergency Departments of Spain. Eur J Emerg Med 2003 (en prensa).
2. MINTEGUI S, BENITO J, VÁZQUEZ MA, FERNÁNDEZ A, GORTÁZAR P, GRAU G. Intoxicaciones en urgencias: cambios epidemiológicos en los últimos 10 años. Rev Esp Pediatr 2002; 56: 23-29.
3. RIQUELME A, BURILLO-PUTZE G, JIMÉNEZ A, HARDISSON A. Epidemiología global de la Intoxicación Aguda en un Área de Salud. Aten Primaria 2001; 28: 506.
4. FRASER AD. Use and abuse of the benzodiazepines. Ther Drug Monit 1998; 20: 481-489.
5. ROBERGE RJ, LIN E, KRENZELOK EP. Flumazenil reversal of carisoprodol (Soma) intoxication. J Emerg Med 2000; 18: 61-64.
6. MINTZER MZ, STOLLER KB, GRIFFITHS RR. A controlled study of flumazenil-precipitated withdrawal in chronic low-dose benzodiacepine users. Psychopharmacology (Berl) 1999; 147: 200-209.
7. LITOVITZ TL, KLEIN-SCHWARTZ W, WHITE S, COBAUGH DJ, YOUNISS J, OMSLAER JC et al. 2000 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 2001; 19: 337-395.
8. ALONSO MP, DE ABAJO FJ, MARTÍNEZ JJ, MONTERO D, MARTÍN-SERRANO G, MADURGA M. Evolución del consumo de antidepresivos en España. Impacto de los inhibidores selectivos de la recaptación de serotonina. Med Clin (Barc) 1997; 108: 161-166.
9. FROMMER DA, KULIG KW, MARX JA, RUMACK B. Tricyclic antidepressant overdose. JAMA 1987; 257: 521-526.
10. BOEHNERT MT, LOVEJOY FH. Value of the QRS duration versus the serum drug level in predicting seizures and ventricular arrhythmias after an acute overdose of tricyclic antidepressants. N Engl J Med 1985; 313: 474-479.
11. FOULKE GE, ALBERTSON TE, WALBY WF. Tricyclic antidepressant overdose: emergency department findings as predictors of clinical course. Am J Emerg Med 1986; 4: 496-500.
12. FOULKE GE, ALBERTSON TE. QRS interval in tricyclic antidepressant overdosage: inaccuracy as a toxicity indicator in emergency settings. Ann Emerg Med 1987; 16: 160-163.
13. NIEMANN JT, BESSEN HA, ROTHSTEIN RJ, LAKS MM. Electrocardiographic criteria for tricyclic antidepressant cardiotoxicity. Am J Cardiol 1986; 57: 1154-1159.
14. LIEBELT EL, FRANCIS PD, WOLF AD. ECG lead a VR versus QRS interval in predicting seizures and arrhythmias in acute tricyclic antidepressant toxicity. Ann Emerg Med 1995; 26: 195-201.
15. GOLDGRAN-TOLEDANO D, SIDERIS G, KEVORKIAN JP. Overdose of cyclic antidepressants and the Brugada syndrome. N Engl J Med 2002; 346: 1591-1592.
16. SCHONWALD S. Medical Toxicology. A sinopsis and study guide. Philadelphia, Lippincott Williams & Wilkins, 2001.
17. LINDEN CH, RUMACK BH, STREHLKE C. Monoamine oxidase inhibitor overdose. Ann Emerg Med 1984; 13: 1137-1144.
18. BROWN T, SKOP B, MARETH T. Pathophysiology and management of the serotonin syndrome. Ann Pharmacother 1996; 30: 527-533.
19. LITOVITZ TL, KLEIN-SCHWARTZ W, RODGERS GC, COBAUGH DJ, YOUNISS J, OSMALES JC et al. 2001 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 2002; 20: 391-452.
20. DUEÑAS A, APARICIO M. Litio. En: Dueñas laita A (Ed). Intoxicaciones agudas en medicina de urgencia y cuidados críticos. Barcelona, Masson 1999: 293-296.
21. BARRUETO F. Antimaniac agents: Lithium and Valproic Acid. En: An intensive review course in clinical toxiclogy. New York City Poison Control Center. New York, 2002; 41-43.
22. JOYE F. Beta-blocker intoxication. Presse Med 2000; 29: 1027-1033.
23. LOVE JN, LITOVITZ TL, HOWELL JM, CLANCY C. Characterization of fatal beta blocker ingestion: a review of the American Association of Poison Control Centers data from 1985 to 1995. J Toxicol Clin Toxicol 1997; 35: 353-359.
24. LOVE JN, ENLOW B, HOWELL JM, KLEIN-SCHWARTZ W, LITOVITZ TL. Electrocardiographic changes associated with beta-blocker toxicity. Ann Emerg Med 2002; 40: 603-610.
25. TABOULET P, CARIOU A, BERDEAUX A, BISMUTH C. Pathophysiology and management of self-poisoning with beta-blockers. J Toxicol Clin Toxicol 1993; 31: 531-551.
26. BORRON SW, BISMUTH C, MUSZYNSKI J. Advances in the management of digoxin toxicity in the older patient. Drugs Aging 1997; 10: 18-33.
27. MAHDYOON H, BATTILANA G, ROSMAN H, GOLDSTEIN S, GHEORGHIADE M. The evolving pattern of digoxin intoxication: observations at a large urban hospital from 1980 to 1988. Am Heart J 1990; 120: 1189-1194.
28. ABAD SANTOS F, CARCAS AJ, IBAÑEZ C, FRÍAS J. Digoxin level and clinic manifestations as determinants in the diagnosis of digoxin toxicity. Ther Drug Monit 2000; 22: 163-168.
29. GONZÁLEZ ANDRÉS VL. Revisión sistemática sobre la efectividad e indicaciones de losanticuerpos antidigoxina en la intoxicación digitálica. Rev Esp Cardiol 2000; 53: 49-58.
30. AMORIM S, DIAS P, ROCHA G, GAMA G, DE CAMPOS M, PIRES S. Poisoning with calcium channel blockers-a case report and review of the literature. Rev Port Cardiol 2001; 20: 1249-1257.
31. ODEH M. Exfoliative dermatitis associated with diltiazem. J Toxicol Clin Toxicol 1997; 35: 101-104.
32. BOYER E, DUIC P, EVANS A. Hyperinsulinemia/euglycecmia therapy for calcium channel blocker poisoning. Ped Emerg Care 2002; 18: 36-37.
33. th Ed. New York, McGraw-Hill, 2002: 762-774.